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tThe first thrombectomy (TE) of an acute iliofemoral
venous thrombosis was reported by Läwen from König-
berg, Germany in 1937.1 The treatment of acute deep vein
thrombosis (DVT) in Europe at this time was dominated by
the philosophy of the French pioneer René Leriche, where
resection of a thrombosed segment of the vein resulted in
sympathectomy and release of vasoconstriction with im-
proved circulation. Läwen described two cases where he
used his “Thrombenkratzer” to remove the thrombus. He
concluded that TE served three purposes: release of the
arterial spasm, prevention of pulmonary embolism, and
release of peripheral stasis and swelling.
At the same time as TE was established, two medical
milestones in Europe paved the way for modern treatment
of DVT: Jorpes’ purification of heparin in 1935, and Dos
Santos’ development of ascending venography in 1938.
Simultaneously, Jorpes and Craaford, in Stockholm, and
Murray and Best, in Toronto, tested heparin in thrombo-
embolic disease. Craaford was able to show from the results
of a large controlled study of 627 patients operated on
between 1937 and 1940 that prophylactically given intra-
venous heparin immediately after surgery for a 7-day dura-
tion totally eliminated thromboembolic complications after
major surgery.2 In the same year that Dos Santos published
his article, Bauer, in Mariestad, Sweden, perfected the
technique of venography and started to use it in clinical
practice to diagnose DVT. After confirmation of diagnosis,
he treated these patients with intravenous heparin, early
ambulation, and compression of the leg.
At a meeting in Stockholm on December 1, 1940, at
the same time as Craaford presented his findings of prophy-
laxis, Bauer reported his early results of 21 patients with
venographically confirmed calf vein thrombosis compared
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doi:10.1016/j.jvs.2011.04.027ith 32 patients with calf vein thrombosis before he had
ccess to heparin. None of the patients in the heparin-
reated group had proximal extension compared with 75%
n the nontreated group, none had clinical pulmonary
mbolism (PE) compared with 34%, and no contralateral
VT developed compared with 31%.3
The history of venous TE in the United States is quite
nteresting and reveals misconceptions that underscore its
urrent infrequent use. John Homans, an advocate for
ivision of the femoral vein to prevent PE, first suggested
E in an article, “Exploration and division of the femoral
nd iliac veins in the treatment of thrombophlebitis of the
eg” presented at the New England Surgical Society meet-
ng at Poland Spring, Maine, on September 28, 1940.4
eferring to the recent European experience, Homans
iscussed indications for TE—with or without ligation of
he femoral vein—the technique, the complications, and
he importance to prevent reflux: “I believe that in the
uture, instead of at once dividing the various femoral
eins . . . it might be permissible to repair the vein and
nstitute for the next few days a vigorous hepariniza-
ion . . . At least, repair without division has safely been
sed even before heparin was available.”
However, the modern era of TE in the United States
tarted with Howard Mahorner’s report, “New manage-
ent for thrombosis of deep veins of extremities” in 1954,
here he advocated TE, followed by restoration of vein
umen and regional heparinization. He presented six pa-
ients, where five had an excellent result with rapid disap-
earance of leg swelling, very little late morbidity, and
inimum leg edema (Fig 1 and Fig 2). There was no PE
efore or after the surgery. He claimed that this method
estored vein function, with preservation of the vein lumen
nd vein valves. In a follow-up article in 1957, he reported
6 patients where TE was performed in 14 legs and two
rms, with excellent results in 12, good in two, and poor in
wo patients.5
The enthusiasm for TE created by Mahorner received
trong support in the report by Haller and Abrams6 in
963. They presented 45 patients with iliofemoral venous
hrombosis who underwent TE. In 34 patients with a short
istory (10 days), excellent bidirectional flow was estab-
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September 2011898 Eklöflished in 31 (91%). At follow-up after an average of 18
months, 26 of these 31 patients (84%) had normal legs, and
where ascending venography was permitted in 13 patients,
normal patency of the deep venous system was demon-
strated in 11 (85%).
However, enthusiasm quickly subsided after Lansing
and Davis7 presented their 5-year follow-up of Haller and
Abrams’ patients in 1968. Of Haller and Abrams’ 34 pa-
tients with a short history, only 17 (50%) were interviewed,
but 16 patients had leg swelling that required stockings,
and an ulcer had developed in one patient. Ascending
venography was performed in 15 patients who were supine,
showing patent veins, but “the involved area of the deep
venous system was found to be incompetent in all cases and
there were no functioning valves.”
Unfortunately, the flaws in the Lansing andDavis study
were not recognized and widely enough discussed: (1) they
studied only half of the original cohort, and likely those
with symptoms that had brought them back to the vascular
clinic, (2) the outstanding late patency of the veins that had
undergone TE was completely ignored, and (3) incompe-
tence of the valves in the femoral and popliteal vein cannot
reliably be assessed from an ascending venographic study in
a supine patient.
In a 1969 publication, “Iliofemoral venous thrombo-
sis: Reappraisal of thrombectomy,” William Edwards ar-
gued with the Lansing results and concluded that,
“venous TE offers an effective and safe method of restor-
Fig 1. A, An incision is made over the deep vein at a level that is
expected to be near the upper end of the clot. B, After the
thrombosed vein is isolated, small rubber tissue drains are placed
beneath it. C, A longitudinal incision is made in the vein. (Re-
printed with permission from Mahorner H. New management for
thrombosis of deep veins of extremities. Am Surg 1954;20:
487-98).ing flow in the deep venous system; when the thrombus is mless than 10 days in duration and is of the iliofemoral
segment, TE is recommended; venograms at operation to
determine the patency of the deep venous system will aid
in complete removal of the thrombus and give a basis for
later comparison and evaluation of long-term patency.”8
In the discussion that followed the article, Lansing
epeated his findings from the 5-year follow-up, still ques-
ioning the value of TE, but Haller, who was never con-
ulted about the follow-up report, stated that, at a recent
isit to Louisville, he had studied 17 patients where total
emoval of the thrombus had been possible and none had
ignificant residual edema.
Despite this rebuttal, the effect of the Lansing study,
ombined with Karp and Wylie’s subsequent one-page
eport in the Surgical Forum of 10 patients in whom eight
ad reocclusion of the femoral vein before discharge (even
hough all had phlegmasia cerulea dolens and extensive
hrombosis) was profound: only a few series on TE were
ubsequently published from the United States, even
hough they all showed very good clinical results in 75%
f patients.9
Surgical TE continued to be the method of choice for
cute iliofemoral DVT inmany centers in Europe and Japan
uring the 1970s and 1980s. Better perioperative manage-
ig 2. A, Compression is made along the course of the vein from
bove while the clot is gently lifted out with an instrument. Then,
ressure from below upward is exerted to remove the clot from the
ower segment. If the flow of blood is free from each direction, it
ndicates that the clot has been adequately removed. B, If blood
ow is not normal, a catheter with suction attached is introduced in
ach segment to remove adherent thrombus. C, The vein is not
igated, but the lumen is restored by suturing the opening with 4-0
ilk. (Reprinted with permission fromMahorner H. New manage-
ent for thrombosis of deep veins of extremities. Am Surg 1954;
0:487-98).ent and the use of a temporary arteriovenous fistula
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Volume 54, Number 3 Eklöf 899improved the results. In a Swedish randomized controlled
trial, venography demonstrated iliac vein patency at 6
months was 76% in the surgical group compared with 35%
in the conservative group. This significant difference was
upheld after 5 and 10 years, with 77% and 83% patency in
the surgical group, respectively, vs 30% and 41% in the
conservative group. As monitored by descending venogra-
phy with Valsalva, femoropopliteal valvular competence at
6 months was 52% in the surgical group compared with
26% in the conservatively treated group, a significant differ-
ence. After 5 years, when the results of all functional tests
were combined, 36% of the surgical patients had normal
venous function compared with 11% of the conservatively
treated group. These differences were not statistically sig-
nificant due to loss of patients. Duplex scanning at 10 years
showed popliteal reflux in 32% of the surgical group com-
pared with 67% of the conservative group.10
NEW DEVELOPMENTS TO IMPROVE TE
There has been a significant improvement of the results
of surgical TE, with the understanding to immediately
restore iliac vein outflow in patients with iliac vein obstruc-
tion as the major cause of their DVT. Control of iliac vein
outflow immediately after TE can be achieved by intraopera-
tive venogram, angioscopy, or intravascular ultrasound imag-
ing. In remaining obstruction, intraoperative endovenous an-
gioplasty and stenting is recommended. Schwarzbach et al11
reported excellent results in 18of 20patients,whomaintained
patency after 21 months of follow-up. To improve patency
and preservation of the valves in the deep veins of the leg,
Blättler et al12 combined TE of the iliac vein with thrombol-
ysis applied under ischemic conditions to the leg veins.
None of the 33 patients in their report experienced
clinically apparent recurrence within the first year. Clin-
ical signs of postthrombotic syndrome were absent in all
but one patient.
With improved outflow through the iliac system by
angioplasty and stenting and with increased inflow from the
improved distal patency by regional thrombolysis, the tem-
porary arteriovenous fistula may not be necessary. An ex-
cellent review of contemporary venous TE was published
by Comerota and Gale in 2006.13
SELECTED INDICATIONS FOR TE IN THE
LATEST AMERICAN COLLEGE OF CHEST
PHYSICIANS GUIDELINES
The American College of Chest Physicians recommen-
dations from 2008 are more in favor of early thrombus
removal than before14:
● In selected patients with extensive acute proximal
DVT (eg, iliofemoral DVT, symptoms for 14 days,
good functional status, life expectancy 1 year) who
have a low risk of bleeding, we suggest that catheter-
directed thrombolysis (CDT) may be used to reduce
acute symptoms and postthrombotic morbidity if ap-
propriate expertise and resources are available.● After successful CDT in patients with acute DVT, we
suggest correction of underlying venous lesions using
balloon angioplasty and stents (Grade 2C).
● We suggest pharmacomechanical thrombolysis (PMT,
eg, with inclusion of thrombus fragmentation and/or
aspiration) in preference to CDT alone to shorten
treatment time if appropriate expertise and resources
are available (Grade 2C).
● In selected patients with acute iliofemoral DVT (eg,
symptoms for7 days, good functional status, and life
expectancy1 year), we suggest that operative venous
TE may be used to reduce acute symptoms and post-
thrombotic morbidity if appropriate expertise and re-
sources are available (Grade 2B). If such patients do
not have a high risk of bleeding, we suggest that CDT
is usually preferable to operative venous TE (Grade
2C).
● In patients who undergo any of these interventions, we
recommend the same intensity and duration of antico-
agulant therapy afterward as for comparable patients
who do not undergo intervention (Grade 1C).
UMMARY
Acute iliofemoral DVT remains a severely debilitating
roblem. Prevention of extension of thrombus, PE, and
ostthrombotic syndrome remain the primary objectives in
reating these patients. Accumulating data now show that
arly removal of thrombus has a better outcome for patients
ompared with anticoagulation alone. Multiple treatment
odalities, such as CDT and percutaneous PMT are now
vailable in addition to surgical TE. In proper hands, per-
utaneous techniques for thrombus removal are becoming
he first-line treatment, with durable outcomes being re-
orted.More clinical trials are needed to assist in determining
ptimal patient selection to improve immediate success, limit
omplications, and provide long-term freedom from disease.
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